Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, <<NOTE: Adding Ebola to the FDA Priority Review Voucher Program Act.>>
This Act may be cited as the ``Adding Ebola to the FDA Priority Review Voucher Program Act''.
DISEASES.
Section 524 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended-- (1) in subsection (a)(3)-- (A) by redesignating subparagraph (Q) as subparagraph (R); (B) by inserting after subparagraph (P) the following: ``(Q) Filoviruses.''; and (C) in subparagraph (R), as so redesignated, by striking ``regulation by'' and inserting ``order of''; and (2) in subsection (b)-- (A) in paragraph (2), by adding ``There is no limit on the number of times a priority review voucher may be transferred before such voucher is used.'' after the period at the end; and
(B) in paragraph (4), by striking ``365 days'' and inserting ``90 days''.
Approved December 16, 2014.
LEGISLATIVE HISTORY--S. 2917: ---------------------------------------------------------------------------
CONGRESSIONAL RECORD, Vol. 160 (2014): Dec. 2, considered and passed Senate. Dec. 3, considered and passed House.
<all>